Breaking News: Ipsen Temporarily Modifies Program for Receiving Somatuline Depot during the Pandemic

Ipsen CARES is temporarily making Somatuline Depot available, at no charge, for eligible patients who cannot get their medicine because they are homebound due to the pandemic, and allowing eligible patients covered by Medicare or Medicaid to participate in Nurse Home Health Administration (NHHA) services.

For more information,  see below or visit Ipsen CARES.

Ipsen CARES offers the Nurse Home Health Administration program to help eligible Somatuline® Depot (lanreotide) patients get the medicine they need.

  • A physician must prescribe Somatuline Depot to be administered by NHHA.
  • The program is available to most patients covered by commercial insurance plans.
    • Ipsen CARES has a new abbreviated form for physicians to use to order NHHA services for patients already enrolled in Ipsen CARES.
  • Patients covered by government healthcare programs, such as Medicare and Medicaid, are not eligible for the program under normal circumstances.
    • However, During the COVID-19 pandemic, Ipsen CARES is temporarily making Somatuline Depot available, at no charge, for eligible patients who cannot get their medicine because they are homebound due to the pandemic, and allowing eligible patients covered by Medicare or Medicaid to participate in NHHA services.
  • Residents of Massachusetts, Michigan, Minnesota, and Rhode Island are not eligible.

Breaking News_3

Print Friendly, PDF & Email